1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Multiple sclerosis

Ocrelizumab for treating primary progressive multiple sclerosis

Technology appraisal guidance [TA585] Published date: 12 June 2019

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Evidence

Review and download supporting evidence. Includes the full guideline if available.

Supporting evidence

  • Evaluation report  
  • Appraisal consultation committee papers PDF 22.13 MB 12 June 2019  
  • Final appraisal determination 1 committee papers PDF 3.4 MB 12 June 2019  
  • Final appraisal determination 2 committee papers PDF 937.09 KB 12 June 2019